224 related articles for article (PubMed ID: 31732870)
1. Salsolinol-neurotoxic or Neuroprotective?
Kurnik-Łucka M; Latacz G; Martyniak A; Bugajski A; Kieć-Kononowicz K; Gil K
Neurotox Res; 2020 Feb; 37(2):286-297. PubMed ID: 31732870
[TBL] [Abstract][Full Text] [Related]
2. Salsolinol, a dopamine-derived tetrahydroisoquinoline, induces cell death by causing oxidative stress in dopaminergic SH-SY5Y cells, and the said effect is attenuated by metallothionein.
Wanpen S; Govitrapong P; Shavali S; Sangchot P; Ebadi M
Brain Res; 2004 Apr; 1005(1-2):67-76. PubMed ID: 15044066
[TBL] [Abstract][Full Text] [Related]
3. Low level of glutathione can intensify the toxic effect of salsolinol in SH-SY5Y neuroblastoma cell line.
Wszelaki N; Melzig MF
Neurotoxicology; 2012 Jun; 33(3):424-8. PubMed ID: 22525935
[TBL] [Abstract][Full Text] [Related]
4. Studies on the neurotoxicity of 6,7-dihydroxy-1-methyl-1,2,3,4-tetrahydroisoquinoline (salsolinol) in SH-SY5Y cells.
Willets JM; Lambert DG; Lunec J; Griffiths HR
Eur J Pharmacol; 1995 Dec; 293(4):319-26. PubMed ID: 8748684
[TBL] [Abstract][Full Text] [Related]
5. Oxidation of N-methyl(R)salsolinol: involvement to neurotoxicity and neuroprotection by endogenous catechol isoquinolines.
Naoi M; Maruyama W; Kasamatsu T; Dostert P
J Neural Transm Suppl; 1998; 52():125-38. PubMed ID: 9564615
[TBL] [Abstract][Full Text] [Related]
6. Salsolinol, an endogenous compound triggers a two-phase opposing action in the central nervous system.
Możdżeń E; Kajta M; Wąsik A; Lenda T; Antkiewicz-Michaluk L
Neurotox Res; 2015 Apr; 27(3):300-13. PubMed ID: 25537852
[TBL] [Abstract][Full Text] [Related]
7. TRPC1 protects human SH-SY5Y cells against salsolinol-induced cytotoxicity by inhibiting apoptosis.
Bollimuntha S; Ebadi M; Singh BB
Brain Res; 2006 Jul; 1099(1):141-9. PubMed ID: 16765919
[TBL] [Abstract][Full Text] [Related]
8. Enantio-specific induction of apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopaminergic SH-SY5Y cells: suppression of apoptosis by N-(2-heptyl)-N-methylpropargylamine.
Maruyama W; Boulton AA; Davis BA; Dostert P; Naoi M
J Neural Transm (Vienna); 2001; 108(1):11-24. PubMed ID: 11261742
[TBL] [Abstract][Full Text] [Related]
9. 1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism.
Storch A; Kaftan A; Burkhardt K; Schwarz J
Brain Res; 2000 Feb; 855(1):67-75. PubMed ID: 10650131
[TBL] [Abstract][Full Text] [Related]
10. Antiapoptotic effects of nicotine in its protection against salsolinol-induced cytotoxicity.
Copeland RL; Das JR; Kanaan YM; Taylor RE; Tizabi Y
Neurotox Res; 2007 Jul; 12(1):61-9. PubMed ID: 17513200
[TBL] [Abstract][Full Text] [Related]
11. PACAP protects against salsolinol-induced toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease.
Brown D; Tamas A; Reglödi D; Tizabi Y
J Mol Neurosci; 2013 Jul; 50(3):600-7. PubMed ID: 23625270
[TBL] [Abstract][Full Text] [Related]
12. Salsolinol Protects SH-SY5Y Cells Against MPP
Kurnik-Łucka M; Latacz G; Goryl J; Aleksandrovych V; Gil K
Neurochem Res; 2023 May; 48(5):1347-1359. PubMed ID: 36449199
[TBL] [Abstract][Full Text] [Related]
13. TRPC1 protects dopaminergic SH-SY5Y cells from MPP+, salsolinol, and N-methyl-(R)-salsolinol-induced cytotoxicity.
Arshad A; Chen X; Cong Z; Qing H; Deng Y
Acta Biochim Biophys Sin (Shanghai); 2014 Jan; 46(1):22-30. PubMed ID: 24252728
[TBL] [Abstract][Full Text] [Related]
14. An endogenous dopaminergic neurotoxin, N-methyl-(R)-salsolinol, induces DNA damage in human dopaminergic neuroblastoma SH-SY5Y cells.
Maruyama W; Naoi M; Kasamatsu T; Hashizume Y; Takahashi T; Kohda K; Dostert P
J Neurochem; 1997 Jul; 69(1):322-9. PubMed ID: 9202326
[TBL] [Abstract][Full Text] [Related]
15. Increased vulnerability of parkin knock down PC12 cells to hydrogen peroxide toxicity: the role of salsolinol and NM-salsolinol.
Su Y; Duan J; Ying Z; Hou Y; Zhang Y; Wang R; Deng Y
Neuroscience; 2013 Mar; 233():72-85. PubMed ID: 23291452
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of nicotine against salsolinol-induced cytotoxicity: implications for Parkinson's disease.
Copeland RL; Leggett YA; Kanaan YM; Taylor RE; Tizabi Y
Neurotox Res; 2005 Nov; 8(3-4):289-93. PubMed ID: 16371323
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of curcumin against rotenone and salsolinol-induced toxicity: implications for Parkinson's disease.
Qualls Z; Brown D; Ramlochansingh C; Hurley LL; Tizabi Y
Neurotox Res; 2014 Jan; 25(1):81-9. PubMed ID: 24122264
[TBL] [Abstract][Full Text] [Related]
18. Neuropathic alterations of the myenteric plexus neurons following subacute intraperitoneal administration of salsolinol.
Kurnik M; Gil K; Gajda M; Thor P; Bugajski A
Folia Histochem Cytobiol; 2015; 53(1):49-61. PubMed ID: 25815627
[TBL] [Abstract][Full Text] [Related]
19. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline (1BnTIQ), an endogenous neurotoxin, induces dopaminergic cell death through apoptosis.
Shavali S; Ebadi M
Neurotoxicology; 2003 Jun; 24(3):417-24. PubMed ID: 12782106
[TBL] [Abstract][Full Text] [Related]
20. Future of neuroprotection in Parkinson's disease.
Naoi M; Maruyama W
Parkinsonism Relat Disord; 2001 Oct; 8(2):139-45. PubMed ID: 11489679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
